Search

Search Constraints

You searched for: Author/Creator Delsart, Pascal

Search Results

1. A pilot double-blind randomized placebo-controlled crossover pharmacodynamic study of the centrally active aminopeptidase A inhibitor, firibastat, in hypertension. Issue 8 (August 2019)

2. Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial. Issue 10 (10th October 2017)

3. Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial. Issue 12 (20th September 2016)

4. ANTIPLATELET AND ANTICOAGULANT THERAPY DURING ANGIOPLASTY PROCEDURES FOR ATHEROMATOUS OR FIBROMUSCULAR DYSPLASIA RENAL ARTERY STENOSIS: A SURVEY OF PRACTICES IN EUROPEAN SOCIETY OF HYPERTENSION EXCELLENCE CENTRES (ESH-EC) IN FRANCE. (June 2022)

5. Aortic morphology post type A acute aortic syndrome: Prognosis significance and association with 24‐hour blood pressure‐monitoring parameters. Issue 5 (16th March 2020)

6. Clinic Versus Ambulatory Blood Pressure in Resistant Hypertension: Impact of Antihypertensive Medication Nonadherence. Issue 5 (November 2019)

7. Clinical significance of unsuspected rise in cardiac troponin in the setting of falls in older people. Issue 6 (18th June 2010)

8. Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis. Issue 22 (13th June 2022)

9. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial. Issue 10367 (3rd December 2022)

10. Editor's Choice – Long-term Survival and Risk Analysis in 136 Consecutive Patients With Type B Aortic Dissection Presenting to a Single Centre Over an 11 Year Period. (May 2019)